Bizarre Patents
Crispy Chip Sandwich and Process of Producing a Sandwich Product
A food product comprising a multilayer cookie or snack having outer layers formed from a crispy type edible food product such as a potato chip or corn chip, etc. with an intermediate marshmallow layer being in contact with the inner surface of each crispy chip and one or more filler substances.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8051884 | Device for combining components by means of negative pressure under sterile conditions The invention relates to a device for combining two components. A first container accommodates the first component, which is liquid, and a second container accommodates a second, solid or liquid component under negative pressure. A body is provided with a first hold... | 11/08/2011 |
| 8012728 | Thrombin preparations and process for their production The production of a thrombin preparation which is obtained from prothrombin which is, after activation to thrombin without the addition of thromboplastin, purified by a hydrophobic interaction chromatography, it being possible subsequently also to inactivate or remo... | 09/06/2011 |
| 7939632 | Proteolytically cleavable fusion proteins with high molar specific activity The invention relates to therapeutic fusion proteins in which a coagulation factor is fused to a half-life enhancing polypeptide, and in which both are connected by a linker peptide that is proteolytically cleavable. The cleavage of such linkers liberates the coagul... | 05/10/2011 |
| 7939288 | Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques The invention relates to a method for determining a factor XIII deficiency, a method for determining a fibrinogen deficiency, and a method for differentiating between a factor XIII deficiency and a fibrinogen deficiency by means of thrombelastographic techniques. On... | 05/10/2011 |
| 7892842 | Procedure for the determination of the activity of the protease which activates factor VII from protein solutions The present application relates to procedures for the determination of the activity of the protease which activates factor VII, also known as factor VII activating protease or FSAP. The application also relates to a method of detecting whether an individual has incr... | 02/22/2011 |
| 7879803 | Methods of treatment involving the protease for activating clotting factor VII This application describes methods of treatment involving a protease for activating the blood clotting factor VII, which (a) activates blood clotting factor VII, (b) is inhibited by the presence of aprotinin, (c) is increased in its activity by the presence of at le... | 02/01/2011 |
| 7863009 | Mutants of the factor VII-activating protease and detection methods using specific antibodies Mutants of the DNA sequence coding for the protease (FSAP) which activates blood clotting factor VII and single-chain plasminogen activators, the mutants comprising a G/C base exchange at nucleotide position 1177 and/or a G/A base exchange at nucleotide position 160... | 01/04/2011 |
| 7863006 | Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies This application includes description of antibodies for specifically detecting prions of human origin and methods for detecting pathogenic prions. In some embodiments, the antibodies bind to an epitope characteristic of a human prion protein which is not found in th... | 01/04/2011 |
| 7829095 | Inhibitory monoclonal antibody against blood clotting factor VII-activating protease A monoclonal antibody which inhibits the blood clotting factor VII-activating protease and its proenzyme and a blood clotting factor VII-activating protease, stabilized by the addition of said monoclonal antibody, and its proenzyme are described. A suitable monoclon... | 11/09/2010 |
| 7803569 | Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations An arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are ... | 09/28/2010 |
| 7625866 | Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto The invention relates to a concentrate and a process for producing a factor VIII:C-containing von Willebrand factor by fractional precipitation from a liquid comprising factor VIII:C and von Willebrand factor, resulting in an increased content of high molecular weig... | 12/01/2009 |
| 7572769 | Fibrin adhesive granulate and method for its preparation The invention relates to a flowable fibrin adhesive granulate containing thrombin, Factor XIII, fibrinogen, and a calcium salt in the form of granules with a particle size of more than 50 μm to 1000 μm. Said granulate is useful for the healing of wounds in surgery... | 08/11/2009 |
| 7550567 | Fibrinogen purification The present invention relates to a process for purifying fibrinogen, which comprises one or more process steps in which one or more contaminating proteins are depleted by negative chromatography and/or negative adsorption using cation exchanger, hydrophobic gel and/... | 06/23/2009 |
| 7491197 | Fluid transfer device Embodiments of the invention include a fluid transfer device, for example, for medical fluids. The device includes a housing, two piercing elements mounted in the housing, and a slide arranged between the piercing elements. The slide may be displaced with respect to... | 02/17/2009 |
| 7442514 | Mutants of the factor VII-activating protease and detection methods using specific antibodies Mutants of the DNA sequence coding for the protease (FSAP) which activates blood clotting factor VII and single-chain plasminogen activators, the mutants comprising a G/C base exchange at nucleotide position 1177 and/or a G/A base exchange at nucleotide position 160... | 10/28/2008 |
| 7351561 | Thrombin preparations and process for their production The production of a thrombin preparation which is obtained from prothrombin which is, after activation to thrombin without the addition of thromboplastin, purified by a hydrophobic interaction chromatography, it being possible subsequently also to inactivate or remo... | 04/01/2008 |
| 7335634 | Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases re... | 02/26/2008 |
